Tina Hambuch, PhD, FACMG, VP of Laboratory Medical and Pathology at Exact Sciences
Dr. Hambuch is currently the VP of Laboratory Medical and Pathology at Exact Sciences. Her focus is on the integration and innovation of molecular test offerings across five laboratories and multiple tests. She entered the field of medical genetics in 2006, just as new technologies were beginning to transform the efficiency, sensitivity and accessibility of genetic testing. She spent two years at Ambry Genetics designing, validating and launching Sanger-based tests and then was recruited by Illumina, where she led a team that launched a CLIA certified, CAP accredited laboratory offering NGS based whole genome sequencing in 2009. In 2016, she joined Invitae, where she held the CLIA license for the San Francisco lab, directed the integration and launch of additional laboratories, and was a critical contributor to the 510k approval for a heritable cancer panel. Tina went to Quest in 2022, and then moved to Exact Sciences in 2024. Tina earned a BS in biology at UC Riverside, a PhD in population genetics at UC Berkeley, was a post doctoral fellow at the Centers for Disease Control, and an assistant professor at LMU in Munich, Germany. She is ABMGG board certified in clinical molecular genetics, and her medical genetics fellowship was at UCLA. She has served on numerous advisory and best practice committees, including ACMG, AMP, FDA, CLIAC, and Genome Canada and has over 35 publications in the field.